# RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

Study · id `cardio:ct-nct05134012` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05134012](<https://clinicaltrials.gov/study/NCT05134012>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05134012

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 232 participants.

## Technical summary

Registry record NCT05134012. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-05-08 (actual); primary completion 2026-10-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 232 participants (enrolled count; ClinicalTrials.gov record NCT05134012, source copy `cardio:ctgov-nct05134012-2026-10-29`, retrieved 2026-10-31)
- Started: 2022-05-08 (actual) (ClinicalTrials.gov record NCT05134012, source copy `cardio:ctgov-nct05134012-2026-10-29`, retrieved 2026-10-31)
- Primary completion: 2026-10-02 (actual) (ClinicalTrials.gov record NCT05134012, source copy `cardio:ctgov-nct05134012-2026-10-29`, retrieved 2026-10-31)
- Completion: 2026-10-02 (actual) (ClinicalTrials.gov record NCT05134012, source copy `cardio:ctgov-nct05134012-2026-10-29`, retrieved 2026-10-31)
- Countries: United States; Canada; Denmark; Germany; Netherlands; Sweden (ClinicalTrials.gov record NCT05134012, source copy `cardio:ctgov-nct05134012-2026-10-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05134012-2026-10-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
- Condition: Coronary Artery Disease
- Intervention (Drug): \[O-15\]-Water PET Myocardial Perfusion Imaging (MPI)
- Lead sponsor: MedTrace Pharma A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: d2f06649c38000b7ae87700a0422ff7964c84138684f62d40e5ab38c7fb1f6dd
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
